Page last updated: 2024-11-04

sulfadiazine and Anemia, Sideroblastic

sulfadiazine has been researched along with Anemia, Sideroblastic in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Anemia, Sideroblastic: Anemia characterized by the presence of erythroblasts containing excessive deposits of iron in the marrow.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Switala, I1
Dufour, P1
Ducloy, AS1
Vinatier, D1
Bernardi, C1
Monnier, JC1
Plantier, I1
Fortier, B1

Other Studies

1 other study available for sulfadiazine and Anemia, Sideroblastic

ArticleYear
[Medullary aplasia during treatment for congenital toxoplasmosis in a twin pregnancy].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 1993, Volume: 22, Issue:5

    Topics: Adult; Anemia, Aplastic; Anemia, Sideroblastic; Cordocentesis; Female; Folic Acid; Folic Acid Defici

1993